Masamitsu Nakao

8PUBLICATIONS
9CO-AUTHORS
Gastroenterology and hepatologyCardiology (incl. cardiovascular diseases)Sport and exercise nutritionClinimetricsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 03, 2025
Nationwide survey of patients with acute liver failure and late-onset hepatic failure in Japan seen between 2016 and 2021.

Nobuaki Nakayama, Masamitsu Nakao, Yoshihito Uchida

|Feb 03, 2022
Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation.

Yoshihito Uchida, Hayato Uemura, Shohei Tsuji

|Sep 04, 2020
Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis.

Yoshihito Uchida, Mie Inao, Shohei Tsuji

|Aug 25, 2020
Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis.

Yoshihito Uchida, Shohei Tsuji, Hayato Uemura

|Dec 15, 2019
Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus.

Shohei Tsuji, Yoshihito Uchida, Hayato Uemura

Pageof 2